69 results
8-K
EX-10.1
GOSS
Gossamer Bio Inc
27 Nov 23
Departure of Directors or Certain Officers
4:01pm
met or removed to the Company’s satisfaction, (ii) as determined by the Company, all other legal matters regarding the issuance and delivery … satisfaction/growth; customer service; employee satisfaction; recruitment and maintenance of personnel; human resources management; supervision of litigation
8-K
EX-99.1
GOSS
Gossamer Bio Inc
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
conditions, the satisfaction of customary closing conditions related to the private placement and the anticipated use of proceeds therefrom, and plans … associated with market conditions and the satisfaction of customary closing conditions related to the proposed financing; and other risks described
8-K
GOSS
Gossamer Bio Inc
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
of such statements due to the risks and uncertainties associated with market conditions and the satisfaction of customary closing conditions related
8-K
EX-10.1
h2x5lndtq5ioe 93k
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
8-K
EX-4.1
85zy014yq
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
8-K
wlm9d
13 Jul 22
Gossamer Bio Announces $120 million Private Placement Financing
8:45am
8-K
EX-99.1
yolj4xep
13 Jul 22
Gossamer Bio Announces $120 million Private Placement Financing
8:45am
8-K
EX-10.1
gmuzyu4k5y0s
13 Jul 22
Gossamer Bio Announces $120 million Private Placement Financing
8:45am
S-3ASR
EX-4.4
z3dgp0llvec of
3 Mar 22
Automatic shelf registration
4:05pm